Biocanvas Competitors

BMC is a pioneer of open access publishing. We’re committed to innovation in research publishing to support the needs of our communities and ensure the integrity of the research we publish. Our leading research journals include selective broad interest titles such as Genome Biology and Genome Medicine, academic journals such as Malaria Journal and Microbiome and the BMC series, 65 inclusive journals focused on the needs of individual research communities. We also partner with leading institutions and societies to publish journals on their behalf. BMC also manages the UK primary clinical trial registry ISRCTN (https://www.isrctn.com).

BioRender is revolutionizing how science is communicated, one graphic at a time (you can think of us as the Adobe or Canva for science!). We're on a mission to accelerate science by empowering all scientists to quickly and easily communicate their research. We are a team of passionate scientists, engineers, science illustrators, designers and entrepreneurs backed by an incredible group of investors, including YCombinator. We nerd out on cool science stuff and solving big problems. We work really hard and sweat the details to deliver a high impact product that our users love.

Geneious develops bioinformatics software for molecular biologists, genomics researchers, and antibody discovery scientists. The Geneious portfolio includes two distinct products, each built for a different research workflow. Geneious Prime is an integrated bioinformatics platform for sequence analysis, cloning design, and genomics. It brings together NGS analysis, Sanger sequencing, sequence alignment, phylogenetics, primer design, and CRISPR tools into a single visual environment. It is designed for researchers who need analytical depth without requiring programming expertise, and is used by molecular biologists and bioinformaticians across academic labs, biotech, and pharma R&D. Geneious Biologics is cloud software purpose-built for antibody discovery and engineering. It processes large NGS antibody sequencing datasets to annotate sequences, cluster clonotypes, assess developability, and integrate experimental assay data. It is designed for antibody discovery scientists and computational biologists at biotech and pharmaceutical companies working on therapeutic programs. Geneious software is used in more than 4,000 universities, research institutes, and businesses across 125 countries. Geneious is part of the Dotmatics portfolio of scientific software.